Scarica l'app Stockscreener
22.02
0.82%
0.18
Dopo l'orario di chiusura:
22.02
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Form 144 COLLEGIUM PHARMACEUTICAL For: 1 October By Investing.com - Investing.com Canada
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - Stock Traders Daily
Former officer Scott Dreyer proposes selling 27,419 Collegium Pharmaceutical (COLL) shares. - Stock Titan
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - uk.finance.yahoo.com
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo! Finance Canada
Collegium Pharmaceutical stock falls 1.45 percent near yearly low - AD HOC NEWS
Collegium Pharmaceutical Price Target Announced at $50.00/Share by Oppenheimer - Moomoo
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform By Investing.com - Investing.com South Africa
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform - Investing.com
Oppenheimer Initiates Collegium Pharmaceutical at Outperform With $50 Price Target - Yahoo Finance
Collegium Pharmaceutical stock holds as market data show no catalyst - AD HOC NEWS
Collegium Pharmaceutical stock edges lower as analysts keep Moderate Buy stance - AD HOC NEWS
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 118% Potential Upside Beckons Investors - DirectorsTalk Interviews
Collegium Pharmaceutical at H.C. Wainwright: pushing beyond pain By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical at H.C. Wainwright: pushing beyond pain - Investing.com
Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45 - Moomoo
(COLL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical stock edges higher after recent quarterly update - AD HOC NEWS
Collegium Pharmaceutical Inc. (COLL) Peer Comparison – Compare with Others - Value Research
Collegium Pharmaceutical Inc. (COLL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
(COLL) Risk Channels and Responsive Allocation - Stock Traders Daily
A Look at Collegium Pharmaceutical Inc (COLL) After 3.9% Decline -- GF Value $47.17 vs Price $26.39 - GuruFocus
Israel A. Englander reports new Collegium (NASDAQ: COLL) stake - Stock Titan
Collegium (COLL) Move: Ends Higher by 2.18% at $27.70 in Latest Trading; Technical View: the $26.31 to $29.09 Range Remains in Focus in the Latest SessionETF NAV Deviation - vinanet.vn
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 - Moomoo
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Canada
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium gains on accelerated share buybacks (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Pharmaceutical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Collegium Pharmaceutical (COLL) Slips 0.85% While Holding Above Key Support at $25.62Value ETF - careplusvn.com
Collegium Pharmaceutical (NASDAQ:COLL) Shares Down 6.5%Here's What Happened - MarketBeat
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - Yahoo Finance
Collegium Pharmaceutical, Inc. Revenue Breakdown – NASDAQ:COLL - TradingView
1.15%
5.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):